Contingencies (Details) $ in Thousands	May 03, 2022 USD ($)	Dec. 09, 2019 cause	Dec. 05, 2019 cause	Mar. 31, 2019 cause
Neurelis, Inc. v. Aquestive Therapeutics, Inc.
Loss Contingencies [Line Items]
Number of cases pending		3	3
Litigation settlement, amount awarded from other party | $	$ 156
Neurelis IPR Litigation
Loss Contingencies [Line Items]
Number of cases pending				3